Accessing Military Health Care During Lapse in Appropriations
The Military Health System will continue to provide health care during a government lapse in appropriations. There may be some effects on the delivery of health care services within military hospitals and clinics. Contact your hospital or clinic to confirm hours of operations and services provided.
Here you will find products from across the Military Health System. Select from the list in the left navigation or use the advanced search:
Are you looking for DHA Publications? All publications are available on DHA SharePoint (CAC required).
We found 864 items
Provides additional clarification and guidance on P&T decisions from May 2025 committee meeting
Provides clinical and cost-effectiveness conclusions for formulary placement of agents based on evaluation by P&T committee and utilization review
Provides clinical and cost-effectiveness conclusions for P&T committee decisions in August 2025 based on evaluation and review of utilization trends.
Provides clinical and cost-effectiveness conclusions for P&T committee decisions based on evaluation and review of utilization trends from the February 2026 meeting
Provides recommendations of the P&T Committee on formulary inclusion of new drugs, drug class reviews, conclusions from utilization management, and final votes
Contains summary of proceedings and recommendations for formulary inclusion and drug class reviews evaluated by P&T Committee in February 2026
Contains clarification and instructions for therapeutic substitution of selected medications and explains P&T authorities for therapeutic substitution
Cumulative P&T minutes for February, May, August and November 2025 P&T meetings reflecting formulary recommendations and final decisions
Contains the summary of proceedings, recommendations and actions from November P&T Committee Meeting
Summarizes the proceedings and recommendations of the P&T committee concerning formulary inclusions and drug class reviews evaluated by P&T committee in November 2025
Clarifies and outlines the process of therapeutic substitution of selected agents and establishes the authority of the P&T Committee in this endeavor
UF BAP EXSUM and Meeting Minutes December 18 2024
UF BAP EXSUM and Meeting Minutes September 25 2024
Provides P&T committee recommendations for formulary inclusion of new drugs, drug class reviews, conclusions from utilization management and final votes
Prior Authorization Medication List with Links to Express-scripts.com formulary webpage
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
You are leaving Health.mil View the external links disclaimer.
